{"id":"https://openalex.org/W2043745591","doi":"https://doi.org/10.1007/s11095-006-9137-8","title":"PAMPA\u2013Excipient Classification Gradient Map","display_name":"PAMPA\u2013Excipient Classification Gradient Map","publication_year":2006,"publication_date":"2006-10-19","ids":{"openalex":"https://openalex.org/W2043745591","doi":"https://doi.org/10.1007/s11095-006-9137-8","mag":"2043745591","pmid":"https://pubmed.ncbi.nlm.nih.gov/17053953"},"language":"en","primary_location":{"id":"doi:10.1007/s11095-006-9137-8","doi":"https://doi.org/10.1007/s11095-006-9137-8","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s11095-006-9137-8","pdf_url":null,"source":{"id":"https://openalex.org/S103865650","display_name":"Pharmaceutical Research","issn_l":"0724-8741","issn":["0724-8741","1573-904X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044678525","display_name":"Stefanie Bendels","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Stefanie Bendels","raw_affiliation_strings":["Pharmaceutical Division, F. Hoffmann-La Roche Ltd., PRBD-C, CH-4070, Basel, Switzerland","Pharmaceutical Division, F. Hoffmann\u2013La Roche Ltd., PRBD-C, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Division, F. Hoffmann-La Roche Ltd., PRBD-C, CH-4070, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Division, F. Hoffmann\u2013La Roche Ltd., PRBD-C, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053422480","display_name":"Oksana Tsinman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Oksana Tsinman","raw_affiliation_strings":["pION INC, 5 Constitution Way, Woburn, Massachusetts, 01801, USA","pION INC, Woburn, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"pION INC, 5 Constitution Way, Woburn, Massachusetts, 01801, USA","institution_ids":[]},{"raw_affiliation_string":"pION INC, Woburn, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109937034","display_name":"Bj\u00f6rn Wagner","orcid":"https://orcid.org/0000-0002-9336-0827","observed_orcids":["https://orcid.org/0000-0002-9336-0827"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Bj\u00f6rn Wagner","raw_affiliation_strings":["Pharmaceutical Division, F. Hoffmann\u2013La Roche Ltd., PRBD-C, CH-4070, Basel, Switzerland","Pharmaceutical Division, F. Hoffmann\u2013La Roche Ltd., PRBD-C, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Division, F. Hoffmann\u2013La Roche Ltd., PRBD-C, CH-4070, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Division, F. Hoffmann\u2013La Roche Ltd., PRBD-C, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000597480","display_name":"Dana Lipp","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dana Lipp","raw_affiliation_strings":["pION INC, 5 Constitution Way, Woburn, Massachusetts, 01801, USA","pION INC, Woburn, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"pION INC, 5 Constitution Way, Woburn, Massachusetts, 01801, USA","institution_ids":[]},{"raw_affiliation_string":"pION INC, Woburn, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049363869","display_name":"Isabelle Parrilla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Isabelle Parrilla","raw_affiliation_strings":["Pharmaceutical Division, F. Hoffmann\u2013La Roche Ltd., PRBD-C, CH-4070, Basel, Switzerland","Pharmaceutical Division, F. Hoffmann\u2013La Roche Ltd., PRBD-C, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Division, F. Hoffmann\u2013La Roche Ltd., PRBD-C, CH-4070, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Division, F. Hoffmann\u2013La Roche Ltd., PRBD-C, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086061678","display_name":"Manfred Kansy","orcid":"https://orcid.org/0000-0002-1786-5874","observed_orcids":["https://orcid.org/0000-0002-1786-5874"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Manfred Kansy","raw_affiliation_strings":["Pharmaceutical Division, F. Hoffmann\u2013La Roche Ltd., PRBD-C, CH-4070, Basel, Switzerland","Pharmaceutical Division, F. Hoffmann\u2013La Roche Ltd., PRBD-C, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Division, F. Hoffmann\u2013La Roche Ltd., PRBD-C, CH-4070, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Division, F. Hoffmann\u2013La Roche Ltd., PRBD-C, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078166589","display_name":"Alex Avdeef","orcid":"https://orcid.org/0000-0002-3139-5442","observed_orcids":["https://orcid.org/0000-0002-3139-5442"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Alex Avdeef","raw_affiliation_strings":["pION INC, 5 Constitution Way, Woburn, Massachusetts, 01801, USA","pION INC, Woburn, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"pION INC, 5 Constitution Way, Woburn, Massachusetts, 01801, USA","institution_ids":[]},{"raw_affiliation_string":"pION INC, Woburn, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5078166589"],"corresponding_institution_ids":[],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":null,"fwci":4.1817,"has_fulltext":false,"cited_by_count":55,"citation_normalized_percentile":{"value":0.9483975,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"23","issue":"11","first_page":"2525","last_page":"2535"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmaceutical-excipients","display_name":"pharmaceutical excipients","score":0.6100000143051147},{"id":"https://openalex.org/keywords/intrinsic-permeability","display_name":"intrinsic permeability","score":0.9039999842643738},{"id":"https://openalex.org/keywords/sparingly-soluble-drugs","display_name":"sparingly soluble drugs","score":0.8859999775886536},{"id":"https://openalex.org/keywords/ionization-constants","display_name":"ionization constants","score":0.8539999723434448},{"id":"https://openalex.org/keywords/weak-acids","display_name":"weak acids","score":0.5770000219345093},{"id":"https://openalex.org/keywords/weak-bases","display_name":"weak bases","score":0.9860000014305115},{"id":"https://openalex.org/keywords/polyethylene-glycol-400","display_name":"polyethylene glycol 400","score":0.7279999852180481},{"id":"https://openalex.org/keywords/sodium-taurocholate","display_name":"sodium taurocholate","score":0.8130000233650208},{"id":"https://openalex.org/keywords/n-methyl-2-pyrrolidone","display_name":"N-methyl-2-pyrrolidone","score":0.7210000157356262},{"id":"https://openalex.org/keywords/polyethylene-glycol","display_name":"polyethylene glycol","score":0.7300000190734863},{"id":"https://openalex.org/keywords/hydroxypropyl-beta-cyclodextrin","display_name":"hydroxypropyl-\u03b2-cyclodextrin","score":0.8090000152587891}],"concepts":[{"id":"https://openalex.org/C2777239854","wikidata":"https://www.wikidata.org/wiki/Q902638","display_name":"Excipient","level":2,"score":0.8162058591842651},{"id":"https://openalex.org/C2984430287","wikidata":"https://www.wikidata.org/wiki/Q186249","display_name":"Pharmaceutical technology","level":2,"score":0.6225671172142029},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.35041117668151855},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.26495784521102905}],"mesh":[{"descriptor_ui":"D002463","descriptor_name":"Cell Membrane Permeability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005079","descriptor_name":"Excipients","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007408","descriptor_name":"Intestinal Absorption","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008567","descriptor_name":"Membranes, Artificial","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s11095-006-9137-8","doi":"https://doi.org/10.1007/s11095-006-9137-8","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s11095-006-9137-8","pdf_url":null,"source":{"id":"https://openalex.org/S103865650","display_name":"Pharmaceutical Research","issn_l":"0724-8741","issn":["0724-8741","1573-904X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Research","raw_type":"journal-article"},{"id":"pmid:17053953","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17053953","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.428600013256073}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W41378874","https://openalex.org/W54789453","https://openalex.org/W74894253","https://openalex.org/W109496764","https://openalex.org/W204391807","https://openalex.org/W424609096","https://openalex.org/W601386163","https://openalex.org/W653330338","https://openalex.org/W658417414","https://openalex.org/W1555994455","https://openalex.org/W1568560565","https://openalex.org/W1570721670","https://openalex.org/W1572793144","https://openalex.org/W1977698867","https://openalex.org/W1994829516","https://openalex.org/W1998700502","https://openalex.org/W2010182430","https://openalex.org/W2015757448","https://openalex.org/W2020485499","https://openalex.org/W2032865438","https://openalex.org/W2050177312","https://openalex.org/W2058540171","https://openalex.org/W2069506489","https://openalex.org/W2076899651","https://openalex.org/W2078130861","https://openalex.org/W2082804431","https://openalex.org/W2104016565","https://openalex.org/W2117277757","https://openalex.org/W2162608794","https://openalex.org/W2485283686","https://openalex.org/W2499551151","https://openalex.org/W2675005138","https://openalex.org/W2953358699","https://openalex.org/W4234156166","https://openalex.org/W4285719527","https://openalex.org/W4300720636","https://openalex.org/W6603029930"],"related_works":["https://openalex.org/W4402661514","https://openalex.org/W2076899651","https://openalex.org/W7120290440","https://openalex.org/W1479873994","https://openalex.org/W2104016565","https://openalex.org/W4409361221","https://openalex.org/W2052659185","https://openalex.org/W2600641158","https://openalex.org/W4391322824","https://openalex.org/W2073879789"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
